INSIGHTS FOR PATENT PROTECTION OF CAR-T CELLS-RELATED TECHNOLOGIES IN BRAZIL

Chimeric antigen receptor (CAR) T-cell therapy is a personalized cancer treatment that is gaining greater visibility and enthusiasm as research advances and success in treating patients is confirmed. In a simplified way, the production of CAR-T cells works as follows:

Fill the form and download our full review of  Insights for
patent protection of car-t cells-related technologies in Brazil

Consent